• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

错配修复缺陷导致的卵巢癌患者的生存情况。

Survival of patients with ovarian cancer due to a mismatch repair defect.

作者信息

Crijnen Th E M, Janssen-Heijnen M L G, Gelderblom H, Morreau J, Nooij M A, Kenter G G, Vasen H F A

机构信息

The Netherlands Foundation for the Detection of Hereditary Tumors, Leiden University Medical Center, Poortgebouw Zuid, 2333 AA, Leiden, The Netherlands.

出版信息

Fam Cancer. 2005;4(4):301-5. doi: 10.1007/s10689-005-6573-2.

DOI:10.1007/s10689-005-6573-2
PMID:16341807
Abstract

PURPOSE

Hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) is characterized by the development of cancer of the colorectum, endometrium and other cancers. Cancer of the ovaries (OC) has frequently been reported in HNPCC. Colorectal cancer associated with HNPCC has a better survival chance compared to sporadic colorectal cancer. It is yet unknown whether patients with OC from HNPCC families (OC-HNPCC) also have a better survival. Therefore, the aim of the study was to compare the survival between patients with OC-HNPCC and a control group.

METHODS

A total of 26 patients with OC were identified from the Dutch HNPCC Registry. A control group (52 cases) matched for age, stage and year of diagnosis was derived from the population-based Eindhoven Cancer Registry. Data on treatment were collected for all patients. Kaplan-Meier analysis was used to calculate the crude survival.

RESULTS

The mean age at diagnosis of OC-HNPCC was significantly lower than the age of sporadic OC (49.5 vs 60.9 years). Compared to sporadic OC, OC-HNPCC was diagnosed at an earlier stage. The survival rate was not significantly different between patients with OC-HNPCC and the controls with sporadic OC. The cumulative 5-year-survival rates were 64.2 and 58.1% respectively.

CONCLUSION

On the basis of our findings, we recommend to treat OC-HNPCC similar to sporadic OC.

摘要

目的

遗传性非息肉病性结直肠癌（HNPCC，林奇综合征）的特征是结直肠癌、子宫内膜癌和其他癌症的发生。卵巢癌（OC）在HNPCC中经常被报道。与散发性结直肠癌相比，HNPCC相关的结直肠癌有更好的生存机会。来自HNPCC家族的OC患者（OC-HNPCC）是否也有更好的生存情况尚不清楚。因此，本研究的目的是比较OC-HNPCC患者与对照组之间的生存率。

方法

从荷兰HNPCC登记处共识别出26例OC患者。对照组（52例）根据年龄、分期和诊断年份进行匹配，来自基于人群的埃因霍温癌症登记处。收集了所有患者的治疗数据。采用Kaplan-Meier分析计算粗生存率。

结果

OC-HNPCC诊断时的平均年龄显著低于散发性OC患者（49.5岁对60.9岁）。与散发性OC相比，OC-HNPCC在更早阶段被诊断出来。OC-HNPCC患者与散发性OC对照组之间的生存率没有显著差异。累积5年生存率分别为64.2%和58.1%。

结论

根据我们的研究结果，我们建议对OC-HNPCC的治疗与散发性OC相似。

相似文献

1
Survival of patients with ovarian cancer due to a mismatch repair defect.错配修复缺陷导致的卵巢癌患者的生存情况。
Fam Cancer. 2005;4(4):301-5. doi: 10.1007/s10689-005-6573-2.
2
Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.丹麦注册研究：与散发性病例相比，III 期结肠癌患者的遗传性非息肉病性结直肠癌的存活率得到改善。
Colorectal Dis. 2013 Jul;15(7):816-23. doi: 10.1111/codi.12150.
3
Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.遗传性非息肉病性结直肠癌（HNPCC）患者与散发性结直肠癌患者的生存情况比较。
Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):209-12.
4
Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌相关子宫内膜癌的生存分析
Int J Cancer. 2002 Nov 10;102(2):198-200. doi: 10.1002/ijc.10667.
5
Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.遗传性结直肠癌患者的生存率：HNPCC和FAP患者的结直肠癌与散发性结直肠癌的比较。
Int J Cancer. 1999 Jan 18;80(2):183-7. doi: 10.1002/(sici)1097-0215(19990118)80:2<183::aid-ijc4>3.0.co;2-w.
6
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.遗传性非息肉病性结直肠癌综合征对卵巢癌发生发展的影响。
Gynecol Oncol. 2006 May;101(2):238-43. doi: 10.1016/j.ygyno.2005.10.029. Epub 2005 Dec 19.
7
Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.遗传性非息肉病性结直肠癌患者与散发性结直肠癌患者的生存率比较。
J Exp Clin Cancer Res. 2008 Sep 19;27(1):39. doi: 10.1186/1756-9966-27-39.
8
Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas.林奇综合征相关卵巢癌与散发性卵巢癌的不同分子特征。
Int J Cancer. 2013 Dec 1;133(11):2596-608. doi: 10.1002/ijc.28287. Epub 2013 Jun 21.
9
Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.BRCA基因无突变的家族性卵巢癌中遗传性非息肉病性结直肠癌的考量
Cancer. 2009 Jan 15;115(2):324-33. doi: 10.1002/cncr.24012.
10
Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.丹麦遗传性非息肉病性结直肠癌家族中妇科癌症的风险
Acta Obstet Gynecol Scand. 2008;87(11):1129-35. doi: 10.1080/00016340802443806.

引用本文的文献

1
Updates in gynecologic care for individuals with lynch syndrome.林奇综合征患者妇科护理的最新进展。
Front Oncol. 2023 Mar 1;13:1127683. doi: 10.3389/fonc.2023.1127683. eCollection 2023.
2
Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma.卵巢透明细胞癌和子宫内膜样癌中错配修复缺陷的频率和临床特征。
J Gynecol Oncol. 2022 Sep;33(5):e67. doi: 10.3802/jgo.2022.33.e67.
3
Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population.

本文引用的文献

1
Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation?携带hMSH2突变的患者中对化疗耐药的卵巢癌？
Fam Cancer. 2001;1(2):107-9. doi: 10.1023/a:1013865323890.
2
Hereditary colorectal cancer.遗传性结直肠癌
N Engl J Med. 2003 Mar 6;348(10):919-32. doi: 10.1056/NEJMra012242.
3
Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌相关子宫内膜癌的生存分析
林奇综合征中的妇科癌症：与普通人群散发性病例的组织学特征比较
J Clin Med. 2022 Jun 27;11(13):3689. doi: 10.3390/jcm11133689.
4
Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.上皮性卵巢癌：提供易感性基因的证据。
Int J Environ Res Public Health. 2022 Jul 1;19(13):8113. doi: 10.3390/ijerph19138113.
5
Cost-effectiveness of prophylactic hysterectomy in first-degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study.美国诊断为结直肠癌的林奇综合征患者一级女性亲属中预防性子宫切除术的成本效益：一项微观模拟研究。
Cancer Med. 2021 Oct;10(19):6835-6844. doi: 10.1002/cam4.4080. Epub 2021 Sep 12.
6
The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance.诱导型一氧化氮合酶在卵巢癌进展和化疗耐药中的潜在作用。
Int J Mol Sci. 2019 Apr 9;20(7):1751. doi: 10.3390/ijms20071751.
7
Women's preferences for cancer risk management strategies in Lynch syndrome.林奇综合征中女性对癌症风险管理策略的偏好。
Gynecol Oncol. 2019 Mar;152(3):514-521. doi: 10.1016/j.ygyno.2018.11.027.
8
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.微卫星不稳定性与林奇综合征泛癌的存在相关。
J Clin Oncol. 2019 Feb 1;37(4):286-295. doi: 10.1200/JCO.18.00283. Epub 2018 Oct 30.
9
Role of tumor microenvironment in ovarian cancer pathobiology.肿瘤微环境在卵巢癌病理生物学中的作用。
Oncotarget. 2018 Apr 27;9(32):22832-22849. doi: 10.18632/oncotarget.25126.
10
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.在铂类药物时代，Ⅰ期子宫内膜样或透明细胞卵巢癌患者的辅助化疗：一项监测、流行病学和最终结果的队列研究，2000-2013 年。
Ann Oncol. 2017 Dec 1;28(12):2985-2993. doi: 10.1093/annonc/mdx525.
Int J Cancer. 2002 Nov 10;102(2):198-200. doi: 10.1002/ijc.10667.
4
Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors.卵巢肿瘤中的微卫星不稳定性、MLH-1启动子高甲基化以及编码单核苷酸重复微卫星处的移码突变。
Cancer. 2001 Dec 1;92(11):2829-36. doi: 10.1002/1097-0142(20011201)92:11<2829::aid-cncr10094>3.0.co;2-3.
5
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌中卵巢癌的临床特征
Gynecol Oncol. 2001 Aug;82(2):223-8. doi: 10.1006/gyno.2001.6279.
6
Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.人错配修复蛋白hMLH1在氟嘧啶介导的细胞死亡和细胞周期反应中的作用。
Cancer Res. 2001 Jul 1;61(13):5193-201.
7
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.2'-脱氧-5-氮杂胞苷诱导hMLH1基因启动子去甲基化逆转人肿瘤异种移植中的耐药性
Cancer Res. 2000 Nov 1;60(21):6039-44.
8
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.hMSH2和GTBP在晚期上皮性卵巢癌中的表达。
Br J Cancer. 1999 Jul;80(10):1665-71. doi: 10.1038/sj.bjc.6690579.
9
Mismatch repair proficiency and in vitro response to 5-fluorouracil.错配修复能力与对5-氟尿嘧啶的体外反应
Gastroenterology. 1999 Jul;117(1):123-31. doi: 10.1016/s0016-5085(99)70558-5.
10
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.遗传性非息肉病性结直肠癌（HNPCC，林奇综合征）国际协作组提出的新临床标准。
Gastroenterology. 1999 Jun;116(6):1453-6. doi: 10.1016/s0016-5085(99)70510-x.